...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Data Expected September 2019 for BETonMACE Phase 3 Cardiovascular Outcomes Trial for Apabetalone

Message: 2019 Potential Events

Pretty much everything has been beaten to death at this late stage. 

While the MD&A and financials are due out by the end of July that still leaves 4 days for the company to deal with the renegotiated maturity date on the loan.  I for one would be very shocked if the loan situation is put to be before August rolls around....its the way Resverlogix rolls. 

End of July we should have a better idea as to the outstanding balance, but not how it will be dealt with.  Will they negotiate another extension? 

We don't even know who the lenders are.


New Message
Please login to post a reply